Delivery Order SPE2DB20D3103-SPE2DB26FL4B6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Nexlizet 180-10 mg tablets in packages of 30 units, with a contract ceiling value of $3,192.92. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 4, 2025. This delivery...
- The Defense Logistics Agency awarded a $1,621.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Nexlizet 180-10 mg tablets (30-count units). This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 1, 2025, and performance to be fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Nexlizet 180-10 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $1,216.50, is non-competitive and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. The award represents a single pharmaceutical product delivery under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $2,294.61 to AmerisourceBergen Drug Corp for Nexlizet 180-10 mg tablets (30-count units) on October 20, 2025, with an ultimate completion date of October 21, 2025. This is a firm fixed price, non-set-aside contract with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under a larger procurement vehicle supporting federal...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for NEXLIZET 180-10 MG tablets in 30-count units, valued at $2,205.61. This firm fixed-price delivery order, with an ultimate completion date of August 1, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor's Corporate Office division. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,946.29 to AmerisourceBergen Drug Corp for Nexlizet 180-10 mg tablets (30-count unit of use packaging) with an ultimate completion date of August 20, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The order represents...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Nexlizet 180-10 mg tablets in a quantity of 30 units, with a ceiling value of $1,201.20. This is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Nexlizet 180-10 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $1,001.00, is scheduled for completion by June 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the company's competitive...
- The Defense Logistics Agency awarded a delivery order valued at $1,266.43 to AmerisourceBergen Drug Corp for the supply of Nexlizet 180-10 mg tablets (30-unit package) on August 5, 2025, with completion targeted for August 6, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and is performed at the contractor's location in Conshohocken, Pennsylvania. As a child contract action under AmerisourceBergen's larger contract vehicle, this delivery order fulfills...
- The Defense Logistics Agency awarded a delivery order valued at $2,893.49 to AmerisourceBergen Drug Corp for the supply of Nexlizet 180-10 mg tablets (30-count units) with an ultimate completion date of October 15, 2025. This is a firm fixed-price, non-set-aside contract awarded competitively on October 14, 2025, with performance to be completed at the vendor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB26FL4B6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Nexlizet 180-10 mg tablets in quantities of 30 units, with a contract ceiling value of $2,744.54. This firm fixed price delivery order, which represents no set-aside designation, is scheduled for completion by October 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical supply vehicle that runs through December 2026 and supports military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, regularly fulfills federal medical procurement requirements through competitively awarded delivery orders with the Defense Logistics Agency. The company's extensive portfolio encompasses a wide range of pharmaceutical products and medical supplies serving Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular delivery order for Nexlizet, a combination medication used in cardiovascular disease management, exemplifies the company's role as a critical vendor in the federal medical supply chain supporting military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 10/28/25 |